Evidence map›Paper›PMID 37581289›Full record

ArticleBrain pathology (Zurich, Switzerland)2024

Myelin protein zero mutation-related hereditary neuropathies: Neuropathological insight from a new nerve biopsy cohort.

Juliane Bremer, Axel Meinhardt, Istvan Katona, Jan Senderek, Elke K Kämmerer-Gassler, Andreas Roos, Andreas Ferbert, J Michael Schröder, Stefan Nikolin, Kay Nolte and 10 more

Open access · goldAbstract read
In one paragraph

Article in Brain pathology (Zurich, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Control of Schwann Cell Myelination by DDR1 Receptor Tyrosine Kinase.International journal of molecular sciences · 2026
    Article
  2. Deferoxamine Improves Radiation-Induced Peripheral Neuropathy.Journal of cellular and molecular medicine · 2026
    Article
  3. Article
  4. Hereditary, non HINT1 related, axonal neuropathy with neuromyotonia.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 2 countries.

Juliane BremerInstitute of Neuropathology, RWTH Aachen University Hospital, Aachen, Germany.ORCID 0000-0002-0268-9425
Axel MeinhardtInstitute of Neuropathology, RWTH Aachen University Hospital, Aachen, Germany.
Istvan KatonaInstitute of Neuropathology, RWTH Aachen University Hospital, Aachen, Germany.
Jan SenderekFriedrich Baur Institute at the Department of Neurology, University Hospital, LMU Munich, Munich, Germany.
Elke K Kämmerer-GasslerInstitute of Pathology, RWTH Aachen University Hospital, Aachen, Germany.
Andreas RoosInstitute of Neuropathology, RWTH Aachen University Hospital, Aachen, Germany.
Andreas FerbertDepartment of Neurology, Klinikum Kassel, Kassel, Germany.
J Michael SchröderInstitute of Neuropathology, RWTH Aachen University Hospital, Aachen, Germany.
Stefan NikolinInstitute of Neuropathology, RWTH Aachen University Hospital, Aachen, Germany.
Kay NolteInstitute of Neuropathology, RWTH Aachen University Hospital, Aachen, Germany.
Bernd SellhausInstitute of Neuropathology, RWTH Aachen University Hospital, Aachen, Germany.
Klimentina PopzhelyazkovaInstitute of Neuropathology, RWTH Aachen University Hospital, Aachen, Germany.
Frank TackeDepartment of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, Campus Virchow-Klinikum (CVK) and Campus Charité Mitte (CCM), Berlin, Germany.
Ulrike Schara-SchmidtDepartment of Neuropaediatrics, University of Essen, Essen, Germany.
Eva Neuen-JacobDepartment of Neuropathology, University Hospital, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
Chantal Ceuterick de GrooteLaboratory of Neuromuscular Pathology, Institute Born-Bunge, and Translational Neurosciences, Faculty of Medicine, University of Antwerp, Belgium.
Peter de JongheLaboratory of Neuromuscular Pathology, Institute Born-Bunge, and Translational Neurosciences, Faculty of Medicine, University of Antwerp, Belgium.
Vincent TimmermanLaboratory of Neuromuscular Pathology, Institute Born-Bunge, and Translational Neurosciences, Faculty of Medicine, University of Antwerp, Belgium.
Jonathan BaetsLaboratory of Neuromuscular Pathology, Institute Born-Bunge, and Translational Neurosciences, Faculty of Medicine, University of Antwerp, Belgium.
Joachim WeisInstitute of Neuropathology, RWTH Aachen University Hospital, Aachen, Germany.ORCID 0000-0003-3280-6773
Universitätsklinikum Aachen · DEUniversity of Antwerp · BEEssen University Hospital · DECharité - Universitätsmedizin Berlin · DEDüsseldorf University Hospital · DEFriedrich Baur Stiftung · DEKlinikum Kassel · DE

Funding

Association Belge contre les Maladies NeuromusculaireEU Horizon 2020 program Solve-RD under grant agreement No 779257Flanders Fund for Scientific Research FWO-FlandersGerman Ministry of Science and Education 01GM1511BGerman Ministry of Science and Education 01GM1511DGerman Research Foundation 1406/13-1German Research Foundation 948/41-1Interuniversity Attraction Poles Programme, Belgian Science Policy IAP P6-43Research Fund - Flanders (FWO) 1805021N
6 · The paper itself

Abstract

Myelin protein zero (MPZ/P0) is a major structural protein of peripheral nerve myelin. Disease-associated variants in the MPZ gene cause a wide phenotypic spectrum of inherited peripheral neuropathies. Previous nerve biopsy studies showed evidence for subtype-specific morphological features. Here, we aimed at enhancing the understanding of these subtype-specific features and pathophysiological aspects of MPZ neuropathies. We examined archival material from two Central European centers and systematically determined genetic, clinical, and neuropathological features of 21 patients with MPZ mutations compared to 16 controls. Cases were grouped based on nerve conduction data into congenital hypomyelinating neuropathy (CHN; n = 2), demyelinating Charcot-Marie-Tooth (CMT type 1; n = 11), intermediate (CMTi; n = 3), and axonal CMT (type 2; n = 5). Six cases had combined muscle and nerve biopsies and one underwent autopsy. We detected four MPZ gene variants not previously described in patients with neuropathy. Light and electron microscopy of nerve biopsies confirmed fewer myelinated fibers, more onion bulbs and reduced regeneration in demyelinating CMT1 compared to CMT2/CMTi. In addition, we observed significantly more denervated Schwann cells, more collagen pockets, fewer unmyelinated axons per Schwann cell unit and a higher density of Schwann cell nuclei in CMT1 compared to CMT2/CMTi. CHN was characterized by basal lamina onion bulb formation, a further increase in Schwann cell density and hypomyelination. Most late onset axonal neuropathy patients showed microangiopathy. In the autopsy case, we observed prominent neuromatous hyperinnervation of the spinal meninges. In four of the six muscle biopsies, we found marked structural mitochondrial abnormalities. These results show that MPZ alterations not only affect myelinated nerve fibers, leading to either primarily demyelinating or axonal changes, but also affect non-myelinated nerve fibers. The autopsy case offers insight into spinal nerve root pathology in MPZ neuropathy. Finally, our data suggest a peculiar association of MPZ mutations with mitochondrial alterations in muscle.

Indexed as

Charcot-Marie-Tooth DiseaseMyelin P0 ProteinBiopsyHumansMutationProteinsMyelin P0 ProteinProteinsCharcot-Marie-toothcongenital hypomyelinating neuropathyinherited neuropathyMPZmyelin protein zero

Identifiers

PMID37581289
PMCPMC10711263
OpenAlexW4385827605

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.